About Geno.Me
Geno.Me is a company based in Milwaukee (United States) founded in 2020 by Britt Gottschalk.. Geno.Me has raised $600 thousand across 2 funding rounds from investors including Gateway Capital. Geno.Me offers products and services including Geno.Me Platform and Contributor Matching Service. Geno.Me operates in a competitive market with competitors including DNAnexus, Genomics, Seven Bridges Genomics, Eagle Genomics and BC Platforms, among others.
- Headquarter Milwaukee, United States
- Founders Britt Gottschalk
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Geno.Me, Incorporated
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$600 K (USD)
in 2 rounds
-
Latest Funding Round
$200 K (USD), Seed
Apr 30, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Geno.Me
Geno.Me offers a comprehensive portfolio of products and services, including Geno.Me Platform and Contributor Matching Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Facilitates sharing health data for clinical trial matching
Connects users to research opportunities for compensation
Unlock access to complete
Backend Team
1 people
Lead Team
1 people
Leadership Team
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Geno.Me
Geno.Me has successfully raised a total of $600K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $200 thousand completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $200,000
-
First Round
First Round
(11 Nov 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Seed - Geno.Me | Valuation |
investors |
|
| Nov, 2021 | Amount | Seed - Geno.Me | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Geno.Me
Geno.Me has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Gateway Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Gateway Capital is engaged in early-stage venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Geno.Me
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Geno.Me
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Geno.Me Comparisons
Competitors of Geno.Me
Geno.Me operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Genomics, Seven Bridges Genomics, Eagle Genomics and BC Platforms, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
|
| domain | founded_year | HQ Location |
Genomic risk assessment and prevention platform is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| domain | founded_year | HQ Location |
Developer of cloud-based software solutions for genomic analysis
|
|
| domain | founded_year | HQ Location |
Platforms for genomic data analysis and management are provided.
|
|
| domain | founded_year | HQ Location |
DNA sequencing technology is developed to detect genomic mutations.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Geno.Me
When was Geno.Me founded?
Geno.Me was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Geno.Me located?
Geno.Me is headquartered in Milwaukee, United States. It is registered at Milwaukee, Wisconsin, United States.
Who is the current CEO of Geno.Me?
Britt Gottschalk is the current CEO of Geno.Me. They have also founded this company.
Is Geno.Me a funded company?
Geno.Me is a funded company, having raised a total of $600K across 2 funding rounds to date. The company's 1st funding round was a Seed of $400K, raised on Nov 11, 2021.
What does Geno.Me do?
Geno.Me was founded in 2020 in Milwaukee, United States, as an online platform in the healthtech sector focused on gene analysis. Electronic health record data is connected with genomic information from external services to support medical research. Contributors who share their data receive monthly compensation, while data privacy and anonymity are maintained throughout operations.
Who are the top competitors of Geno.Me?
Geno.Me's top competitors include DNAnexus, Eagle Genomics and Seven Bridges Genomics.
What products or services does Geno.Me offer?
Geno.Me offers Geno.Me Platform and Contributor Matching Service.
Who are Geno.Me's investors?
Geno.Me has 1 investor. Key investors include Gateway Capital.